Frontiers | Benefit and Risk on Drug-drug Interactions in Infections

Benefit and Risk on Drug-drug Interactions in Infections

663
Total downloads
3,218
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 24 Feb 2025

Changes in the blood cyclosporine level after switching from voriconazole to isavuconazole in a patient with aplastic anemia: insights from physiologically based pharmacokinetic model simulation and the Adverse Event Reporting System database study

Chihiro Shiraishi
Hideo Kato
Kazuko Ino
Takuya Iwamoto

doi 10.3389/fmicb.2025.1525991

101 views

ORIGINAL RESEARCH

Published on 08 Oct 2024

Drug–drug interactions between letermovir and tacrolimus in Japanese renal transplant recipients simulated using a physiologically based pharmacokinetic model

Takumi Maruyama
Hidefumi Kasai
Yutaka Fukaya
Mitsuru Shiokawa
Toshimi Kimura
Yukihiro Hamada

Drug–drug interactions between letermovir and tacrolimus in Japanese renal transplant recipients simulated using a physiologically based pharmacokinetic model

doi 10.3389/fmicb.2024.1480874

920 views

MINI REVIEW

Published on 05 Sep 2024

Drug–drug interactions in the management of non-tuberculous mycobacterial infections

Kazuaki Takeda
Takahiro Takazono
Hiroshi Mukae

Drug–drug interactions in the management of non-tuberculous mycobacterial infections

doi 10.3389/fmicb.2024.1468383

889 views
1 citation

Share on

Frontiers in Microbiology

Frontiers in Microbiology

Antimicrobials, Resistance and Chemotherapy

Impact

3,218Topic views
1,703Article views
663Article downloads